These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Triethylene melamine in the treatment of Hodgkin's disease and allied neoplasms. RHOADS CP; KARNOFSKY DA; BURCHENAL JH; CRAVER LF Trans Assoc Am Physicians; 1950; 63():136-46. PubMed ID: 14855568 [No Abstract] [Full Text] [Related]
6. Rheumatic manifestations in Hodgkin's disease, leukaemia and allied conditions. PAQUET E; DELAGE JM Can Med Assoc J; 1957 Jun; 76(11):927-33. PubMed ID: 13426945 [No Abstract] [Full Text] [Related]
7. Clinical experience with physostigmine in the treatment of arthritis and allied diseases. CLYBOURNE HE J Am Osteopath Assoc; 1952 Mar; 51(7):341-2. PubMed ID: 14907430 [No Abstract] [Full Text] [Related]
8. The practical aspects of the diagnosis, treatment, and prognosis of Hodgkin's disease and allied disorders. JACKSON H Radiology; 1948 Apr; 50(4):481-5. PubMed ID: 18917088 [No Abstract] [Full Text] [Related]
9. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V; J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450 [TBL] [Abstract][Full Text] [Related]
10. Laparotomy in the re-evaluation of patients with advanced Hodgkin's disease. Kostraba NC; Peterson BA; Kennedy BJ; Grage TB; Bloomfield CD Cancer Treat Rep; 1981; 65(7-8):685-7. PubMed ID: 7248986 [TBL] [Abstract][Full Text] [Related]
11. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. Ng AK; Bernardo MP; Weller E; Backstrand KH; Silver B; Marcus KC; Tarbell NJ; Friedberg J; Canellos GP; Mauch PM J Clin Oncol; 2002 Apr; 20(8):2101-8. PubMed ID: 11956271 [TBL] [Abstract][Full Text] [Related]
12. The pathologist's role in management of patients with Hodgkin's disease. Dorfman RF; Colby TV Cancer Treat Rep; 1982 Apr; 66(4):675-80. PubMed ID: 7074637 [TBL] [Abstract][Full Text] [Related]
13. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. Kant JA; Hubbard SM; Longo DL; Simon RM; DeVita VT; Jaffe ES J Clin Oncol; 1986 Mar; 4(3):284-94. PubMed ID: 3754003 [TBL] [Abstract][Full Text] [Related]
14. [Hodgkin's lymphoma]. Jyrkkiio S; Mokka M; Vasala K Duodecim; 2014; 130(9):913-20. PubMed ID: 24881143 [TBL] [Abstract][Full Text] [Related]
15. Enzyme histochemistry of the cells in Hodgkin's disease and allied disorders. DORFMAN RF Nature; 1961 Jun; 190():925-6. PubMed ID: 13723879 [No Abstract] [Full Text] [Related]
16. Prognostic significance of primary site after radiotherapy in non-Hodgkin's lymphomata. Musshoff K; Schmidt-Vollmer H Br J Cancer Suppl; 1975 Mar; 2():425-34. PubMed ID: 1101929 [TBL] [Abstract][Full Text] [Related]